It is unclear, however, whether P2RX7 plays a role in non-alcoholic steatohepatitis (NASH) and which cell type is the main target of P2RX7 pharmacological inhibition. This evidence concerns the gene P2RX7 and metabolic dysfunction-associated steatohepatitis.